Revised SPC: Kalydeco (ivacaftor) - all formulations
The indication in SPC has been updated to include use in patients who are 6 years and older with R117H CFTR mutation.
Source:
electronic Medicines compendium
The indication in SPC has been updated to include use in patients who are 6 years and older with R117H CFTR mutation.
electronic Medicines compendium